Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma in Vivo

DJ Gross, I Reibstein, L Weiss, S Slavin, H Dafni… - Clinical cancer …, 2003 - AACR
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …
被引用次数：48 相关文章

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - Clinical …, 2003 - … .esploro.exlibrisgroup.com
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …
[PDF] academia.edu

[PDF][PDF] Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma in Vivo

DJ Gross, I Reibstein, L Weiss, S Slavin, H Dafni… - academia.edu
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - Clinical Cancer …, 2003 - weizmann.elsevierpure.com
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - … : an official journal …, 2003 - pubmed.ncbi.nlm.nih.gov
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - Clinical …, 2003 - weizmann.esploro.exlibrisgroup.com
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

[引用][C] Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ GROSS, I REIBSTEIN, L WEISS… - Clinical cancer …, 2003 - pascal-francis.inist.fr
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau
pheochromocytoma in vivo CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.

DJ Gross, I Reibstein, L Weiss, S Slavin… - … Cancer Research: an …, 2003 - europepmc.org
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - Clinical …, 2003 - weizmann.esploro.exlibrisgroup.com
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …

Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo

DJ Gross, I Reibstein, L Weiss… - Clinical …, 2003 - … .esploro.exlibrisgroup.com
Halofuginone has recently been shown to inhibit tumor progression of various types of
cancers. The antitumoral effect was associated with decreased tumor angiogenesis rather …